PELOSI, GIUSEPPE
PELOSI, GIUSEPPE
Dipartimento di Oncologia ed Emato-Oncologia
3q26 amplification and polysomy of chromosome 3 in squamous cell lesions of the lung : a fluorescence in situ hybridization study
2007 G. Pelosi, B. Del Curto, M. Trubia, A.G. Nicholson, M. Manzotti, G. Veronesi, L. Spaggiari, P. Maisonneuve, F. Pasini, A. Terzi, A. Iannucci, G. Viale
5 '-Nucleotidase (CN-II) emerges as a new predictive biomarker of response in the gemcitabine-cisplatin treatment of non-small cell lung cancer
2011 F. Toffalorio, T. De Pas, E. Giovannetti, D. Radice, G. Spitaleri, D. Galetta, M. Manzotti, R. Danesi, G. Pelosi, L. Spaggiari, F. De Braud
5'-nucleotidase cN-II emerges as a new predictive biomarker of response to gemcitabine/platinum combination chemotherapy in non-small cell lung cancer
2018 F. Toffalorio, M. Santarpia, D. Radice, C. Jaramillo, G. Spitaleri, M. Manzotti, C. Catania, L. Jordheim, G. Pelosi, G. Peters, C. Tibaldi, N. Funel, L. Spaggiari, F. de Braud, T. De Pas, E. Giovannetti
A critical appraisal of the adjuvant chemotherapy guidelines for patients with completely resected T3N0 non-small-cell lung cancer
2010 T. De Pas, S. Raimondi, G. Pelosi, L. Spaggiari, F. De Braud, G. Veronesi, P. Maisonneuve
A FOLFIRI-induced complete tumor response in a patient with FOLFOX-refractory metastatic duodenal adenocarcinoma
2010 C. Catania, G. Pelosi, N. Fazio, R. Biffi, G. Spitaleri, C. Noberasco, M.G. Zampino, A. Maggioni, G. Trifirò, F. Toffalorio, P.D. Vigna, F. De Braud, T. De Pas
A modified vimentin histological score helps recognize pulmonary sarcomatoid carcinoma in small biopsy samples
2012 G. Pelosi, F. Melotti, A. Cavazza, G. Rossi, P. Maisonneuve, P. Graziano, M. Barbareschi, Y. Nakatani, M. Papotti
A primary pure yolk sac tumor of the lung exhibiting CDX-2 immunoreactivity and increased serum levels of alkaline phosphatase intestinal isoenzyme
2006 G. Pelosi, F. Petrella, M.T. Sandri, L. Spaggiari, D. Galetta, G. Viale
A randomized trial of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkers
2003 A. Decensi, C. Robertson, G. Viale, F. Pigatto, H. Johansson, E.R. Kisanga, P. Veronesi, R. Torrisi, M. Cazzaniga, S. Mora, M.T. Sandri, G. Pelosi, A. Luini, A. Goldhirsch, E.A. Lien, U. Veronesi
A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer
2011 F. Bianchi, F. Nicassio, M. Marzi, E. Belloni, V. Dall'olio, L. Bernard, G. Pelosi, P. Maisonneuve, G. Veronesi, P.P. Di Fiore
A subset of high-grade pulmonary neuroendocrine carcinomas shows up-regulation of matrix metalloproteinase-7 associated with nuclear beta-catenin immunoreactivity, independent of EGFR and HER-2 gene amplification or expression
2005 G. Pelosi, A. Scarpa, G. Veronesi, L. Spaggiari, B. Del Curto, P.S. Moore, P. Maisonneuve, A. Sonzogni, M. Masullo, G. Viale
Absence of epidermal growth factor receptor gene mutations in patients with hormone refractory prostate cancer not responding to gefitinib
2007 G. Curigliano, G. Pelosi, T. De Pas, G. Renne, O. De Cobelli, M. Manzotti, G. Spitaleri, F. de Braud
Adjuvant surgery after carboplatin and VP16 in resectable small cell lung cancer
2007 G. Veronesi, P. Scanagatta, F. Leo, T. De Pas, G. Pelosi, G. Catalano, S. Gandini, F. De Braud, L. Spaggiari
Alteration of the E-cadherin/β-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids
2005 G. Pelosi, A. Scarpa, G. Puppa, G. Veronesi, L. Spaggiari, F. Pasini, P. Maisonneuve, A. Iannucci, G. Arrigoni, G. Viale
Alterations of the Notch pathway in lung cancer
2009 B. Westhoff, I.N. Colaluca, G. D'Ario, M. Donzelli, D. Tosoni, S. Volorio, G. Pelosi, L. Spaggiari, G. Mazzarol, G. Viale, S. Pece, P.P. Di Fiore
Alterations of ubiquitin ligases in human cancer and their association with the natural history of the tumor
2009 S. Confalonieri, M. Quarto, G. Goisis, P. Nuciforo, M. Donzelli, G. Jodice, G. Pelosi, G. Viale, S. Pece, P.P. Di Fiore
An open-label, single-arm, phase 2 study of the Aurora kinase A inhibitor alisertib in patients with advanced urothelial cancer
2016 A. Necchi, S. Lo Vullo, L. Mariani, D. Raggi, P. Giannatempo, G. Calareso, E. Togliardi, F. Crippa, N. Di Genova, F. Perrone, M. Colecchia, B. Paolini, G. Pelosi, N. Nicolai, G. Procopio, R. Salvioni, F.G. De Braud
Angiogenin and the MMP9-TIMP2 axis are up-regulated in proangiogenic, decidual NK-like cells from patients with colorectal cancer
2018 A. Bruno, B. Bassani, D.G. D'Urso, I. Pitaku, E. Cassinotti, G. Pelosi, L. Boni, L. Dominioni, D.M. Noonan, L. Mortara, A. Albini
Annual or biennial CT screening versus observation in heavy smokers : 5-year results of the MILD trial
2012 U. Pastorino, M. Rossi, V. Rosato, A. Marchianò, N. Sverzellati, C. Morosi, A. Fabbri, C. Galeone, E. Negri, G. Sozzi, G. Pelosi, C. La Vecchia
Are two better than one? A novel double-mutant KIT in GIST that responds to Imatinib
2013 E. Conca, C. Miranda, V. Dal Col, E. Fumagalli, G. Pelosi, M. Mazzoni, M. Fermeglia, E. Laurini, A. Pierotti, S. Pilotti, A. Greco, S. Pricl, E. Tamborini
Assessment of overdiagnosis in CT screening for lung cancer
2010 G. Veronesi, M. Bellomi, P. Maisonneuve, G. Pelosi, M. Casiraghi, C. Rampinelli, L. Spaggiari